The forecast for the import of antisera and other blood fractions to Argentina shows a consistent upward trend from 2024 to 2028. Starting at $876.36 million in 2024, it is expected to reach $970.34 million by 2028. This indicates a steady growth in demand, with an annual increase in value ranging from $24.21 million to $23.79 million over the forecasted period. The year-on-year growth rate demonstrates a stable market, with a compound annual growth rate (CAGR) showcasing moderate but steady growth over these five years.
Looking ahead, key trends to watch include advancements in medical technology, changes in healthcare policies, and global health dynamics, which could significantly impact the import volumes of antisera and other blood fractions. Additionally, Argentina’s economic conditions and currency fluctuations could influence import costs and demand levels.
